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Radiation leukemia virus (RadLV)1 is a naturally occurring, B-tropic, leukemogenic 
murine leukemia virus  (MuLV)  which is obtained  from radiation-induced  thymic 
lymphomas of strain  C57BL/Ka  mice  (1,  2).  Previous  studies  have  shown that  the 
thymus is essential for the replication of the virus (3) and the neoplastic transformation 
of infected cells (4, 5). We report here the development of extrathymic lymphoblastic 
lymphomas in RadLV-inoculated athymic nude mice, the establishment in vitro of a 
permanent cell line from such lymphoma cells, and the biochemical, serological,  and 
biological characterization  of the virus produced by this lymphoma cell line. 
We have also characterized  the RadLV-induced lymphomas with respect to several 
immunological and enzymatic markers. These studies demonstrate that the neoplastic 
cells are of T-lineage despite the absence of the thymus.  Further characterization  of 
the stage of differentiation of the T-cell lymphomas reveals that their antigenic profile 
resembles  that  of mature peripheral  T  cells.  Alternative  hypotheses concerning the 
origin of the target cells for RadLV lymphomagenesis in athymic mice are discussed. 
Materials and Methods 
Mice.  C57BL/Ka  mice bred  in  this  laboratory  and  congenitally  athymic  nude  (nu/nu) 
mice on the BALB/c or NIH/Swiss background and their thymus-bearing heterozygote (nu/+) 
littermates, originally obtained from the National Cancer Institute, Bethesda,  Md., were used 
in these experiments. Mice of either sex were 4 wk old when used. 
Viruses.  RadLV  was  prepared  as  a  20%  cell-free extract  of RadLV-induced  C57BL/Ka 
thymic lymphomas in phosphate-buffered  saline  (PBS)  as previously described  (5).  The virus 
isolate RadLV/rVLs was obtained from culture fluids of a RadLV-induced C57BL/Ka thymic 
lymphoma cell line (BL/VL3)  permanently established  in cuhure. 2 The virus harvested  from 
the supernatant  fluids of the nude  mouse lymphoma cell line (BALB/Nul)  described  in this 
report- has been designated RadLV/Nux. 
Cells and Culture Conditions.  Suspension cultures of the BALB/Nul lymphoma cell line were 
maintained in RPMI-1640  medium supplemented with  10% heat-inactivated fetal calf serum, 
* Supported, in part, by research  grants CA-03352 and CA-10372 from the National Cancer Institute, 
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2  X  10  -s M  2-mercaptoethanol, 2 mM  L-glutamine, and antibiotics. Cell suspensions from 
spleen,  lymph nodes,  and  thymus were  obtained by mincing each  tissue and  passing the 
kuspension through a  nylon cloth into PBS  (pH  7.4) supplemented with 5% fetal calf serum. 
Viable, nucleated cells were counted and the cell concentration adjusted to levels suitable for 
the various assays. 
Immunofluorescence (IF)  Test for Detection of MuL V Antigen.  Indirect IF staining of acetone- 
fixed cells was performed according to Hilgers et al. (6). The antisera used in this assay have 
been described (7). Values reported for percent MuLV antigen-positive  cells were calculated as 
described by Decl/~ve et al. (3). 
Membrane IF  for Detection of Ig and Thy-l.2 Determinants.  Anti-Thy-  1.2 serum (AKR anti-C3H) 
was kindly supplied by Dr. Israel Zan-Bar, Division of Immunology, Department of Medicine, 
Stanford University. Fluoresceinated rat anti-mouse Ig, IgG, and IgM sera were obtained from 
Cappel Laboratories, Inc., Cochranville, Pa. All sera were used at dilution 1:10 in PBS. Cells 
previously washed in PBS with 5% fetal calf serum were incubated with anti-Thy-l.2  serum for 
30 min at room temperature. They were then washed, incubated with fluoresceinated serum for 
30 min at 4°C, washed again, and placed on the wells of toxoplasmosis slides  (Bellco Glass, 
Inc., Vineland, N.J.). The slides were dried, fixed in acetone for 10 min, mounted with glycerol- 
PBS  1:1  mixture and examined with a  Zeiss fluorescence microscope equipped with a  dark 
field condenser, exciter filter B6 12, barrier filters (50 and 66) and a high pressure mercury bulb 
(HBO 220 W).  The same cell  suspension could thus be examined for the presence of both 
surface Ig and Thy-l.2 antigens: the frequency of cells positive for Thy-l.2 was derived by 
subtracting the number of cells showing fluorescence after incubation with anti-Ig serum only 
from those which were positive after sequential exposure to anti-Thy-l.2 and anti-Ig. 
Quantitative Absorption Tests and Antisera.  The cells used for absorption were obtained from 
confluent cultures or from actively growing tumors. Cell suspensions were made in PBS, washed 
twice,  and samples of different cell numbers distributed into U-shaped well microtiter plates. 
The plates were spun at 900 rpm for 10 min and the cells resuspended in 50/tl of antiserum. 
The antiserum dilution used for absorption was approximately one twofold dilution below the 
endpoint of 50% cytotoxicity of each serum. Cells and antiserum were incubated on ice for 1 h 
with frequent shaking. The plates were then centrifuged at  1,500 rpm for  15 min in the cold 
and 30 #1 of antiserum was removed and stored at -70°C. 
The absorbed antisera were tested in direct cytotoxicity assays by the method of Amos et al. 
(8), as modified by Frelinger et al. (9). The final results were expressed  as: 
% absorption by test cells -  % absorption by negative controls 
percent specific absorption = 
% absorption by positive controls. 
The antisera used in this assay  were  heat-inactivated (56°C for  30 min) before use. Anti- 
Thy-l.2 serum has been described above and was absorbed at dilution 1:2,500, at which it kills 
80%  of C57BL/Ka  thymocytes.  Anti-TL serum  was  raised  in our  own  laboratory against 
C57BL/TL +  thymocytes in C57BL/Ka mice. For absorption it was diluted 1:64. Anti-Ly-1.2 
(C3H/An  anti-CE/J thymocytes)  and  anti-Ly-2.2 [(C3H/An  ×  C57BL/6-Ly  2.1)F1 anti- 
ERLD] sera were obtained from Dr.  F.-W. Shen, Memorial Sloan-Kettering Cancer Center, 
New York. Both were used for absorption at  1:80 dilution. Anti-Gix serum was obtained from 
Dr. Elizabeth Stockert, Memorial Sloan-Kettering Cancer Center, New York. It was produced 
in 0N/Fu X BN)F1 rats against W/Fu leukemia (C58NT)D. It was absorbed with Gtx negative 
thymocytes at  1  : 10 dilution before use. The final dilution for absorption was  1:640. 
Terminal Deoxynucleotidyl Transferase (TdT) Assay.  The TdT assay was performed according 
to Pazmifio et al. (10). The reaction mixture consisted of 2/zg oligo(dA)12-1s, 0.05 M Tris, pH 
8.3, 2 mM dithiothreitol (DTT), 0.6 mM MnCl2, 210 pmol [aH]dGTP (35,500 cpm/pmol), and 
2,100 pmol of cold dGTP, in 100 #l containing 30/zl of each phosphocellulose fraction. Under 
these conditions, the reactivity incorporated for 30 min was linear with enzyme concentration. 
1 U  of enzyme activity is defined as the amount catalyzing the incorporation of 1 pmol of 
dGTP per hour into acid insoluble material. Specific  activity was  calculated from the total 
enzyme activity recovered in phosphocellulose from 10  s viable nucleated cells. 
Radiolabeling of the  Viral Proteins.  Suspension cultures of BALB/Nul cells were seeded  at  1 
×  l05 cells/ml. After 2 days incubation, the culture fluid was changed to L-leucine-free medium 
with  10%  dialyzed  fetal  calf serum,  containing either  0.25  p.Ci/ml  of  [14C]L-leucine (284 1294  T-CELL  LYMPHOMA INDUCTION IN ATHYMIC  NUDE  MICE 
mCi/mmol) or 10 pCi/ml of [SH]L-leucine (5 Ci/mmol). To label viral RNA, [SH]uridine (30 
Ci/mmol) was used at a concentration of 5 pCi/ml. Viruses were harvested from culture after 
18-20  h  of labeling. All isotopes were obtained from New England Nuclear Corp., Boston, 
Mass. 
Virus Purification.  The  supernatant  fluid of exponentially growing cell cultures was  first 
clarified at 4°C by centrifugation at 2,000 g for 15 rain, followed by a second centrifugation at 
7,000 g for 20 rain. Viruses were pelleted at 35,000 g for 3 h at 4°C, resuspended after overnight 
incubation with TNE buffer (20 mM Tris hydrochloride, pH 7.5, 100 mM NaCI, 1 mM EDTA) 
at  0°C  and  spun  through  discontinuous  (15-55%  wt/vol  in  TNE)  sucrose  gradients  in  a 
Beckman L5-50 (SW-40 rotor) ultracentrifuge at 40,000 rpm for 3 h. Material sedimenting to 
the interface was collected by piercing the bottom of the tube, slowly diluted in TNE buffer, 
layered on a continuous sucrose gradient (15-55% wt/vol in TNE) and spun in a Beckman L5- 
50  (SW-40 rotor) ultracentrifuge at 40,000 rpm for 3 h. A gradient-collecting device was used 
to separate 0.5-ml fractions. For detection of radiolabeled maeromolecules, 10-/xl aliquots of 
each fraction were precipitated with  10%  triehloroaeetic acid (TCA), filtered on Whatman 
GF/C  filter papers, extensively washed  with  cold 0.5  M  HCI,  and  counted  in  a  Toluene- 
Omnifluor scintillation fluid. Sucrose densities of the fractions were measured with a  Bausch 
and Lomb Abbe refraetometer (Bausch & Lomb, Scientific Optical Products Div., Rochester, 
N. Y.). Protein content was monitored by adsorbance at 280  nm with a  Zeiss PM 6 speetro- 
photometer (Carl Zeiss, Inc., New York). 
Radioimmune Precipitation Assay.  The assay for [3H]L-leueine labeled RadLV/Nul virus was 
performed with rabbit antisera against the envelope glyeoprotein (gp71) of the BALB:virus-2 
xenotropie virus, AKR MuLV gp71, and RadLV/VLs virus. After a  1-h incubation at 25°C 
with serial dilutions of the primary antiserum, the secondary antiserum, a goat anti-rabbit IgG 
(Huntington  Research Center, Brooklandville, Md.), was added and  the mixture incubated 
overnight at 4°C. Aliquots were then removed from each sample, precipitated with 10% TCA, 
filtered on GF/C paper filters, extensively washed with cold 0.5  M  HCI, and counted in a 
toluene-omnifluor based scintillation fluid. The remainder of the precipitation mixture was 
then spun for 20 min at 3,000 g to pelletize the immunopreeipitate, dried at room temperature, 
dissolved in NCS-tissue solubilizer (Amersharn Corp., Arlington Heights, Ill.) at 50°C for 30 
min, and counted as above. The values are expressed as percentages of counts recovered from 
the immunoprecipitate versus the counts recovered from the samples before centrifugation. 
Electrophoretic Analysis of Viral Proteins.  Radiolabeled viral proteins of isopyenieally banded 
viruses were resolved by sodium dodeeyl sulphate-polyacrylamide gel electrophoresis (SDS- 
PAGE) as described by Witte et al. (11). The differentially  radiolabeled proteins of two different 
viruses were compared by coelectrophoresis on the same gel. 
Assay of RNA-Dependent DNA  Polymerase (RT).  The assay was performed as described by 
Lieber et al. (12), modified by incubation at 30°C, pH 8.1 with 0.25 A260 U of (rA)n and 0.025 
A260 U  of (dT)12-1s per ml. 
Electron Microscopy.  Purified RadLV/Nul viral particles, fixed with osmium tetroxide vapors, 
were stained with  1% uranyl acetate for  15-30 s, mounted on Parlodion-coated copper grids 
(Ted Pella Co., Tustin, Calif.), air dried, and examined on a Phiiips EM 300 electron microscope 
(Philips, Eindhoven, The Netherlands) at 80 kV. Cells were fixed in 2.5%  glutaraldehyde in 
phosphate buffer, postfixed in 2% osmium tetroxide, and processed for dehydration embedding 
and sectioning as already described (13). Thin sections were examined on a  Siemens electron 
microscope (Siemens, Berlin, W. Germany) at 80 kV, through the courtesy of Dr. K. Benseh, 
Department of Pathology, Stanford University. 
Results 
Induction of Lymphornas by RadL V in Athymic Nude Mice.  Athymic nude (nu/nu)  mice 
derived on BALB/c and on NIH/Swiss backgrounds were used in these experiments 
(Table I). RadLV was injected intracranially. Since nude mice are immunodepressed, 
they show  a  very high  mortality. In  the present experiments,  142  NIH/Swiss nude 
mice were injected, but only eight mice reached the age of 9 mo. 
Among the injected BALB/c nude animals, lymphoblastic lymphomas developed P.  RICCIARDI-CASTAGNOLI,  M. LIEBERMAN, O.  FINN, AND H. S. KAPLAN 
TABLE I 
Incidence of Lymphomas in RadL V-Infected Nude Athymic Mice 
1295 
Virus  Mouse type  Lymphomas/  Latent pc- 
mice*  riod 
%  mo 
RadLV  BALB/c nude (nu/nu)  3/5  60  3-4 
RadLV  NIH/Swiss nude (nu/nu)  1/8  12  8 
(Controls)  NIH/Swiss nude (nu/nu)  0/35  --  -- 
* Denominator is the number of virus-infected nude mice surviving to the age at which the 
first lymphoma appeared. 
in three (60%) of five mice surviving to the age at which the first lymphoma developed. 
Only one (12%) of eight injected NIH/Swiss nude animals surviving to the correspond- 
ing age developed a lymphoblastic lymphoma. As shown in Table I, the latent period 
for these tumors was much longer in NIH/Swiss nude mice (8 mo) than in BALB/c 
nude mice (3-4 mo). Because BALB/c mice are of Fv-1 bb genotype, these results are 
consistent  with  the  previously demonstrated  B-tropic  nature  of RadLV  (14).  At 
autopsy, the tumor-bearing mice had greatly enlarged lymph nodes and moderately 
enlarged spleens. Histological examination showed a diffuse lymphoblastic lymphoma 
involving the lymph nodes and spleens of the tumor-bearing mice (Fig.  1). Indirect 
immunofluorescence staining demonstrated the presence of MuLV antigens in 100% 
of the BALB/e nude and NIH/Swiss nude lymphoma cells (Fig. 2). 
Establishment  of a  Virus-Producing Nude  Mouse Lymphoma  Cell  Line  in  Culture.  A 
permanent cell line was established from a BALB/c nude lymphoma and designated 
BALB/Nul. The cells grow readily in stationary suspension culture. When injected 
intraperitoneally  in  mice  of different strains,  the  cells  are  highly tumorigenic  in 
BALB/c (100% takes progressing to death in 1 mo) and in NIH/Swiss nude (nu/nu) 
mice, but are poorly tumorigenic in NIH/Swiss nude (nu/+) heterozygotes. They are 
not tumorigenic in normal NIH/Swiss and C57BL/Ka mice (Table II). 
The typical electron micrographic appearance of BALB/Nul cells is shown in Fig. 
3. The nucleus of these cells is characterized by diffuse ehromatin and by a  hyper- 
trophic nucleolus which is generally rectangular in shape. The cytoplasm contains 
numerous free ribosomes as well as rosettes of polysomes. Mitochondria and lysosomes 
are present but endoplasmic reticulum is scarce. The Golgi apparatus, when visualized, 
is well developed. The ultrastructural appearance is therefore very similar to that of 
a typical stimulated lymphocyte. Numerous viral particles are seen in the extracellular 
space or budding from the plasma membrane of such cells. Fig. 3 (insert) shows that 
they are C-type particles,  100 nm in diameter. 
Physicochemical and Serological Characterization of RadL V/Nua  Virus.  Fig. 4 shows the 
acid  precipitable  radioactivity  of  [3H]uridine  and  of  [aH]L-leueine-labeled 
RadLV/Nul virus, after purification on sucrose gradients by isopycnic banding. RT 
activity coincided with that of [3H]labeled material in the  1.15-1.17  g/cm  s density 
region of the gradient. A sample of the peak material, negatively stained and examined 
with the electron microscope, showed large numbers of typical C-type viral particles. 
Fig. 5 shows the protein patterns observed when [SH]L-leucine-labeled RadLV/Nul 
was coelectrophoresed with [14C]c-leucine-labeled RadLV/VL3 in a  10% polyacryl- 
amide gel. The major core proteins (p30) of both viruses migrate in identical positions, 
but the major envelope protein (gp71)  of RadLV/Nul is not well demonstrated. For ~
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Flo.  2.  Immunofluorescent staining of NIH/Swiss nude tumor cells with a-MuLV serum for the 
detection of cytoplasmic viral antigens. The lymphoma cells were stained by indirect immunofluo- 
rescence as described in Materials and Methods and examined by fluorescence  microscopy. 
TABLE II 
Transplantability of BALB/Nul Lymphoma Cells 
Strain  Mice  Lymphomas  Latent period 
No. (%) 
C57BL/Ka  15  0  -- 
NIH/Swiss nude (nu/nu)  15  15 (100)  2-3 wk 
NIH/Swiss nude (nu/+)  28  6  (20)  2-3 wk 
BALB/c  I0  10 (100)  2-3 wk 
NIH/Swiss  10  0 
both viruses, the positions of p15, p12, and pl0 are essentially identical.  Recently, it 
has been reported that oncornaviruses can be typed into defined subgroups by tryptic 
digest peptide mapping of the major core protein  (p30)  (15). By this method, the p30 
tryptic peptide profiles of RadLV/VLz and RadLV/Nul  were both found to belong 
to the  12B subtype (J.  Gautsch, personal communication). 
The envelope antigens of RadLV/Nux were identified by the radioimmunoprecip- 
itation  assay,  using  [3H]L-leucine-labeled  virus  and  rabbit  antisera  raised  against 1298  T-CELL  LYMPHOMA  INDUCTION IN ATHYMIC NUDE  MICE 
Fio.  3.  Electron  micrograph of BALB/Nut cells. The ultrastructural appearance is very similar to 
that of a typical stimulated lymphocyte. Viral particles, easily detected in the extracellular space, 
are shown in the insert. They are C-type particles, 100 nm in diameter. (magnification: ×  10,000; 
insert, ×  41,500) 
intact  RadLV/VLa  virions, and against  the gp71 of a  xenotropic virus, BALB:virus- 
2, and of ecotropic AKR-MuLV  (16). The resulting titration  curves (Fig. 6) indicate 
the presence, on the RadLV/Nul  envelope, of antigens common to, or cross-reacting 
with, the envelope antigens of RadLV/VLa, and to a  lesser extent, of xenotropic and 
ecotropic MuLVs. 
Further evidence of cross-reactivity between the gp71 determinants of RadLV/Nul 
and RadLV/VLa was obtained by use of the membrane immunofluorescence (MIF) 
technique.  BALB/Nul cells were incubated with a  1:10 dilution of a rabbit antiserum 
raised  against  purified  gp71  of RadLV/VLa,  followed by treatment  with  a  fluores- 
ceinated goat anti-rabbit serum. As shown in Fig. 7, the cells producing RadLV/Nul 
were stained by the RadLV/VLa gp71 antiserum, while control preparations exposed P.  RICCIARDI-CASTAGNOLI,  M.  LIEBERMAN,  O.  FINN,  AND  H.  S.  KAPLAN  1299 
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to normal rabbit serum and fluoresceinated secondary serum remained negative. 
Biological  Characteristics  of RadLV/Nu]  Virus.  RadLV/Nu]  has  been  assayed  for 
leukemogenicity in  vivo and  for tropism both in  vivo and  in  vitro. The virus was 
obtained from fresh supernatant  fluids of BALB/Nul cells, which were clarified by 
centrifugation at 8,000 g for 15 min and filtration through 0.22 #m Millipore filters. 
The in vivo experiments were performed in C57BL/Ka and NIH/Swiss nude (nu/nu) 
and heterozygotic (nu/+) mice. The results are summarized in Table III. RadLV/Nul 
had thymotropic (T +) and leukemogenic (L +) activity only in C57BL/Ka mice (Fv- 
1  bb  genotype).  Although  the  intrathymic,  intravenous,  and  intracranial  routes  of 
inoculation all yielded lymphomas, the incidence was  much greater and  the latent 
period for lymphoma induction was shorter when the virus was inoculated intrathy- 
mically.  Neither NIH/Swiss  nude homozygotes (nu/nu)  nor heterozygotes (nu/+) 
were susceptible to RadLV/Nul. 
When  assayed  for  infectivity by  the  in  vitro  immunofluorescence assay  (7)  on 
fibroblastic cell lines of Fv-1" and Fv-1 bb genotype, RadLV/Nul replicated poorly 
on Fv-1 bb fibroblasts and failed to replicate on Fv-1 ~  fibroblasts (Table IV). It also P.  RICCIARDI-CASTAGNOLI, M.  LIEBERMAN,  O.  FINN, AND  H.  S.  KAPLAN  1301 
FIG.  7.  Immunofluorescent staining of BALB/Nul cells with antiserum to RadLV/VLs gp71.  The 
cells  were stained  by  indirect  immunofluorescence as  described  in  Materials  and  Methods  and 
examined by fluorescence microscopy. 
TABLE III 
Leukemogenicity and Tropism of RadL V/  Nul 
Lymphoma  Tumor localization  Latent  Mouse strain inoculated  Mice  Injection route  incidence  period 
(%)  mo 
C57BL/Ka  10  Intravenous  20  Thymic  6-9 
C57BL/Ka  8  Intrathymic  80  Thymic and disseminated  3-6 
C57BL/Ka  11  Intracranial  9  Thymic  9 
NIH/Swiss nude (nu/nu)  39  Intracranial  0  --  -- 
NIH/Swiss nude (nu/nu)  17  Intravenous  0  --  -- 
NIH/Swiss nude (nu/+)  10  Intrathymic  0  --  -- 
NIH/Swiss nude (nu/+)  7  Intracranial  0  --  -- 
replicated, albeit poorly, on fibroblastic cells derived from other species,  such as mink 
lung cells,  and thus has some xenotropic activity. When assayed for infectivity on 
thymic lymphoma cell lines of Fv-1 nn and Fv-1 bb genotype, RadLV/Nul replicated to 
high titers in Fv-1 bb cells, and failed to replicate in Fv-1  nn  lymphoma cells. Thus, it is 
clearly a  B-tropic, ecotropic, and thymotropic virus, again resembling RadLV and 
RadLV/VLa (16-18). 
RadLV/Nul has also been tested for its capacity to induce syncytium formation in 
rat XC cells after 3 days of cocultivation with BALB/Nua cells, using the reverse XC 
assay described by Niwa et al. (19). Small, clear plaques composed of multinucleated 1302  T-CELL  LYMPHOMA  INDUCTION  IN  ATHYMIC  NUDE  MICE 
"FABLE IV 
In Vitro Replication of RadL V/Nux 
Cell line  Fv-1 genotype  Tropism of infecting virus  Titer 
Fibroblasts 
NIH/3T3  Fv- 1  ~ 
BL-5  Fv-1 bb 
Mink lung cells 
Thymocytes* 
BL/RL12  Fv- 1  bb 
C57L  Fv- 1  ~ 
N-tropic, ecotropic, fibrotropic  0 
B-tropic, ecotropic, fibrotropic  102 
Xenotropic  10  a 
B-tropic, ecotropic, thymotropic  l0  s 
N-tropic, ecotropic, thymotropic  0 
* Lymphoma  cell  lines established  from  radiation-induced  lymphoid  tumors of C57BL/Ka  and 
C57L mice, respectively. 2 
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FIG.  8.  Correlation between the number of infected BALB/Nu~ cells plated and XC cell plaque 
number after 3 days of cocultivation. 
giant-cell syncytia were observed. There was a linear correlation between the number 
of virus-producing BALB/Nul cells plated and the number of plaques formed (Fig. 
8). 
Characterization  of  Lymphoma  Celts  in  Nude Mice  by  Enzymatic and  Immunological 
Markers.  Previous  studies  of RadLV-induced  leukemogenesis  in  C57BL/Ka  mice P.  RICCIARDI-CASTAGNOLI, M.  LIEBERMAN, O.  FINN, AND H. S.  KAPLAN 
TABLE V 
TdT Activity of Nude Mouse Lymphomas and of Normal Lymphoid Tissues 
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Cell line  Original tissue  Original strain  Age 
Enzyme units*/10  s cells 
Peak I  Peak  II  Total 
m 
BALB/Nul 
m 
BL/VLs 
mo 
Spleen  NIH/Swiss nude  1  6  3  9 
Spleen and 
nodes 
(Lymphoma)  NIH/Swiss nude  8  14  78  92 
Spleen and 
nodes 
(Lymphoma)  BALB/c nude  4  53  29  82 
Thymus 
(Lymphoma)  C57BL/Ka  4  315  546  861 
Thymus 
(Lymphoma)  C57BL/Ka  4  221  565  786 
Thymus  C57BL/Ka  4  298  332  630 
* 1 U of enzyme activity is defined as the amount catalyzing the incorporation of 1 pmol  of dGTP per hour 
into acid insoluble material. 
have shown that  the thymus is essential  for the replication  of the virus  (3)  and the 
transformation of infected cells (4,  5).  The occurrence of extrathymic lymphoblastic 
lymphomas in RadLV-inoculated athymic nude mice suggested the possibility that 
RadLV may be able to transform a different type of target cell under these conditions. 
Therefore, experiments were designed to characterize the T- or B-cell nature of the 
nude mouse lymphoma cells and of the derived cell line. 
Detection of TdT Activity.  This  enzyme  is  selectively localized  in  the  thymus  of 
various  animal  species  (20-22)  and  therefore  appears  to  be  a  specific  marker  for 
thymocytes.  Recently,  it  has  also  been  detected  at  very low  levels in  mouse  bone 
marrow (23,  24).  When marrow cell preparations are fractionated on discontinuous 
bovine serum albumin (BSA) gradients, levels of TdT activity similar to those seen in 
thymocytes are  detected  in  one  fraction,  A  (24).  In  contrast,  lymphoid  organs  of 
athymic nude mice, even after cellular fractionation on BSA gradients, showed TdT 
values which  were only  10% of those observed in  normothymic nude  heterozygotes 
(25). 
Normal lymphoid cells of nude mice, as well as the lymphomas induced by RadLV 
inoculation,  were tested  for TdT  activity by the  phosphocellulose chromatography 
technique  (10).  The typical TdT profile obtained with C57BL thymocytes revealed 
two peaks of enzyme activity. Peak I eluted at approximately 0.22-0.24 M  KCI and 
peak II eluted at approximately 0.28-0.30  M  KC1. The two peaks were consistently 
observed and maintained their relative difference in elution positions. 
The results obtained with nude mice are summarized in Table V. Normal spleen 
cells from NIH/Swiss nude mice showed extremely low amounts of peak I and peak 
II TdT activities, compared with those ofC57BL/Ka thymocytes. The total enzymatic 
activity of lymphoma cells obtained from spleen and lymph nodes of nude mice was 
about  10-fold higher than that of control nude spleen cells; when peak activities were 
considered separately, the lymphoma cell peak II activity was 26-fold higher. Similar 
levels were  found  in  the  BALB/Nua  lymphoma cell  line.  The  fact  that  both  nude 
mouse  lymphomas  exhibited  an  approximately  10-fold  increase  in  TdT  activity 1304  T-CELL LYMPHOMA INDUCTION IN ATHYMIC NUDE MICE 
TABLE VI 
Pattern of Cell Surface Antigens as Detected by MIF 
Mouse strain  Cell type  Thy-1.2  +  Ig  +  IgG  +  IgM  + cells 
BALB/c nude  BALB/Nul  88*  0  0  0 
NIH/Swiss nude 
Lymphoma cells  95  5  4  2 
Lymph node cells  4  78  75  58 
Spleen cells  2  48  45  32 
C57BL/Ka 
BL/VL3  98  0  0  0 
Thymocytes  95  2  2  0 
Spleen cells  30  52  48  30 
* Percent positive  cells. 
relative to normal young NIH/Swiss nude spleen cells suggests that  the  tumor cell 
population,  which  would  be  expected  to  be  much  more  homogeneous,  may  be 
specifically  enriched  for  a  cell  type  that  bears  low  but  significant  TdT  activity. 
However, the TdT activity of nude mouse lymphomas was much lower than that of 
RadLV-induced C57BL/Ka thymie lymphomas (Table V). It has been demonstrated 
that the involved spleen and lymph nodes oflymphoma-bearing AKR or C57BL mice 
express TdT activities (for peak I) about equal to those in the thymus. Thus, it seems 
unlikely that  the low values in the nude mouse lymphomas are due to the fact that 
spleen  and  lymph  nodes,  rather  than  thymus,  were  assayed.  If the  nude  mouse 
lymphomas had resulted  from the transformation and clonal proliferation of a  rare 
pre-existing thymocyte, the lymphoma cells might have been expected to be as highly 
TdT  positive  (for peak I)  as  thymic lymphomas arising in  C57BL/Ka  mice.  Con- 
versely, the fact that the nude mouse lymphomas demonstrate unequivocally positive, 
though low, TdT activity indicates  that the tumor cells are not of B-cell lineage.  In 
fact, it  has been reported  that  normal lymph nodes and spleens of thymus-bearing 
mice are consistently TdT negative (10). 
Detection of Ig and  Thy-l.2 Determinants by Membrane Immunofluorescence.  The results 
are summarized in Table VI. Although  almost all BALB/Nul cells were positive for 
Thy-l.2 (Thy-l.2 +), the intensity of the label was weak and the distribution on the 
cell  surface  spotty  and  granular,  rather  than  homogeneous  (Fig.  9).  Conversely, 
BALB/Nua  cells  did  not  express  Ig determinants  either  on  their  surface  or  in  the 
cytoplasm (as detected by prefixation of the cells in acetone). The NIH/Swiss nude 
mouse lymphoma cells gave similar results; 95% were fluorescent after treatment with 
anti-Thy-l.2 serum. The very small percentage of Ig+  cells is attributed  to a  minor 
contaminating B-cell population in the involved tissues. Much higher percentages of 
Ig +  cells were noted in normal nude mouse lymph nodes and spleens, whereas these 
tissues  contained  very  low  levels  (2-4%)  of  Thy-l.2+  cells,  in  agreement  with 
previously published observations (26-28). These results may be compared with those 
obtained with normal C57BL mice and with BL/VL3 lymphoma cells (Table VI). All 
BL/VL3 cells were fluorescent  when  treated with  anti-Thy-l.2 serum  and  failed to 
fluoresce when treated with anti-Ig sera. 
Antigen Testing by Absorption.  The presence of T-cell markers (Thy- 1, TL, Ly- 1, and 
Ly-2)  on  BALB/Nul  cells  in  vitro  and  after  in  vivo  passage,  as  well  as  on  the 
NIH/Swiss  nude  mouse  lymphoma  in  vivo,  was  tested  by  their  ability  to  absorb 
antibody from specific antisera (as described in Materials and Methods). C57BL/Ka P.  RICCIARDI-CASTAGNOLI, M.  LIEBERMAN, O.  FINN,  AND  H.  S.  KAPLAN  1305 
FIG.  9.  Immunofluoreseent staining of BALB/Nul cells with a-Thy-l.2 serum. 
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FIG.  I0.  Specific  absorption  of anti-Thy-l.2  antiserum  by  the  BALB/Nul  cell  line  in  vitro 
(O-----O), and in vivo (O---O), and by NIH/Swiss nude lymphoma, primary tumor (O  O), and 
first transplant  (O---O). 
thymocytes used at the same range of cell concentrations (105-10  s) as the tested tumor 
cells  absorbed  over 90%  of anti-Thy-l.2 antiserum  activity even at  the  lowest cell 
concentration, and  thus  served as  a  maximal  absorption control. The nude mouse 
spleen had no detectable absorption activity and served as the negative control. Fig. 
10 shows the specific absorption data for the nude mouse lymphoma cells. Both the 
BALB/Nux cell line and the in vivo derived tumor showed moderately high levels of 
Thy-l.2  antigen  as  evidenced  by  their  capacity  to  absorb  anti-Thy-l.2  antibody 
activity. After passage in nu/nu recipients, the level ofThy-1.2 antigen on BALB/Nuz 
lymphoma  cell  transplants  increased  significantly.  Approximately  l0  s  BALB/Nul 1306  T-CELL LYMPHOMA INDUCTION IN ATHYMIC NUDE MICE 
TABLe VII 
Presence of T-Cell Markers in Nude Mouse Lymphomas 
Cells used for absorption* 
Antisera absorbed 
aThy-l.2  aLy-l.2  aLy-2.2  aTL  aGix 
BALB/Nul in vitro 
BALB/Nul transplant in NIH/(nu/nu) 
BALB/Nux transplant in NIH/(nu/+) 
NIH/Swiss nude lymphoma 
NIH/Swiss nude tumor 1st transplant 
++++~ 
++  -  +++  -  + 
++++  -  ++  -  + 
++++  -  ++  -  + 
+  +  +  +  NT§  NT  NT  NT 
++++  -  +++  -  + 
* 1 x  l0  s cells used for absorption. 
~ 0-25% specific absorption  ffi  +; 25-50%  ffi  +  +; 50-75%  ffi  +  +  +;  75-100%  ffi  +  +  +  +. 
§ NT, not tested. 
cells in vitro were required to absorb 50% of anti-Thy-l.2 activity, as compared with 
less  than  105  cells  after in  vivo passage.  The  NIH/Swiss  nude  mouse  lymphoma 
showed levels of Thy-1.2 surface antigen higher than those expressed by the cell line 
in  vitro.  Approximately 5  ×  105 cells sufficed for 50%  absorption of anti-Thy-l.2 
activity. As in the case of the cell line, however, after transplantation of the original 
tumor into secondary recipients, higher levels of Thy-1.2 were observed, less than 105 
cells  being required  for 50%  absorption.  This  may be due  to selection of Thy-l.2 
positive cells from the initially heterogeneous cell population in the primary tumor. 
The NIH/Swiss nude mouse lymphoma and the BALB/Nul cell line were devoid 
of TL antigen  (Table VII).  Normal C57BL/Ka TL  + thymocytes served as positive 
absorption control and  as  target cells, and  the TL- congenic strain was  used  as a 
negative control. Unexpected results were obtained with anti-Ly-l.2 and anti-Ly-2.2 
antisera.  As  shown  in  Table VII,  neither the  tumors  nor the cell line showed  the 
presence of detectable Ly-1.2 surface antigen. However, they all had significant levels 
of Ly-2.2 antigen. Approximately 5  ×  107 cells absorbed 50% ofanti-Ly-2.2 antiserum 
activity. Thus, these tumor cells appear to have the antigenic profile of a  mature T 
lymphocyte subpopulation:  Thy-1  +, Ly-l-, Ly-2  +, TL-. Nonetheless, their levels of 
T-cell antigens are considerably lower than those on the peripheral T  cells of normal 
mice. 
Discussion 
The  successful  induction  of extrathymic  lymphoblastic  lymphomas  in  RadLV- 
inoculated athymic nude mice was an essential prerequisite to the study of RadLV 
replication  patterns  in  congenitally athymic animals.  However, the  relatively low 
incidence  and  the  long  latent  period  of these  tumors  would  not  have  permitted 
meaningful investigations if it had not been possible to establish a permanent cell line 
from one of these tumors. The BALB/Nul cell line was successfully established and 
has been extensively characterized. The cells are highly tumorigenic and 100% positive 
when assayed by indirect immunofluorescence staining for the detection of MuLV 
antigens.  Morphologically they have the typical ultrastructural appearance of stim- 
ulated lymphocytes (29). Large numbers of type C viral particles are released into the 
extracellular spaces.  From the  supernatant  fluid of these  in  vitro cultures,  a  virus 
designated RadLV/Nul has been isolated and characterized. RadLV/Nul is an RNA 
virus  which  labels  with  [SH]uridine,  bands  in  isopycnic gradients at  a  density  of P.  RICCIARDI-CASTAGNOLI,  M.  LIEBERMAN, O. FINN, AND H. S. KAPLAN 1307 
1.15-1.17  g/cm  a,  and  exhibits  reverse transcriptase  activity in  the  banded  region. 
Protein  analysis by  the  SDS-PAGE  technique  showed  the  presence  of the  major 
polypeptides typically observed  in other MuLV and  a  profile identical to  that  of 
RadLV/VLa, a virus produced by a RadLV-induced C57BL/Ka thymic lymphoma 
cell line permanently established in culture (16,  18). 
Moreover, when [aH]L-leueine labeled RadLV-Nua was assayed by immunopreeip- 
itation with a  rabbit  anti-RadLV/VLa serum, it was completely precipitated. The 
same technique demonstrated limited activity with antisera to the purified gp71  of 
xenotropic virus and AKR-MuLV. We also observed the ability of RadLV/Nul to 
cross-react with the gp71  of RadLV/VLa, using the membrane immunofluorescence 
technique  on  the  virus  producing  cells.  Recently,  it  has  been  demonstrated  by 
competition radioimmunoassay with purified virion polypeptides that  the gp71  of 
RadLV/VLa is distinctively different from that of several other MuLVs (18). Thus, 
the results obtained with RadLV/Nul indicate the apparent serological identity of 
the two RadLV-derived viruses. 
The biological characteristics of RadLV/Nul, determined both in vivo and in vitro, 
demonstrate that RadLV/Nul has thymotropie (T  +) and leukemogenic (L  +) activity 
and is  B-tropic.  RadLV/VLs virus shows identical properties  (18).  When  injected 
into C57BL/Ka mice, RadLV/Nul induces thymic lymphoblastic lymphomas which 
have the same characteristics as those obtained after RadLV/VLa injection. 
The antigenic profile of the NIH/Swiss nude mouse lymphoma cells and of the 
BALB/Nul cell line, as detected by specific absorption, was found to be Thy-1 +, Ly- 
1.2-, Ly-2.2  ÷, and TL-. Thy-l.2 antigen was also detected by membrane immunoflu- 
orescence staining, but at much lower intensity levels than those exhibited by normal 
thymocytes. Ig determinants could not be detected by this technique on the NIH/Swiss 
nude mouse lymphoma or the BALB/Nua cells. Taken together, these results suggest 
that these cells have developed along the T-cell differentiation pathway. Moreover, 
their  antigenic  profile  places  them  further  along  the  maturation  scale  than  the 
prothymocyte. 
It has been reported (30) that a rabbit antiserum obtained by immunization with 
nude mouse spleen cells has strong lytic activity against cytotoxic T-cells (Ly-2,3) of 
thymus-bearing mice but that it does not recognize T helper cells (Ly- 1). This suggests 
the possibility that Ly-2,3 cells normally exist in the spleens of nude mice. If so, such 
cells might undergo transformation and clonal expansion into a tumor after infection 
with a leukemogenic virus. In preliminary studies (data not shown) we have detected 
low levels of absorption of anti-Ly-2.2 activity by nude mouse spleen lymphocytes. 
However, these results would not in any case exclude the alternative possibility of 
virus-induced differentiation of prothymocytes, leading to the expression of Thy-l.2 
and Ly-2.2. Precedent exists for such a  response, because it has been reported  (31) 
that viral hepatitis infection can greatly increase the amount of Thy-l.2 antigen in 
nude mouse spleens. Similar increases can be induced by treatment with thymopoietin, 
ubiquitin, cyclic AMP, or levamisole (25, 31, 32). 
It  has  been  demonstrated  that  the  presence  of a  thymus  is  necessary  for  the 
expression of high levels of TdT activity. In nude mice this enzyme has been found 
mainly in bone marrow cells fractionated on BSA gradients. Even then, the activity 
was only about  10%  of that detected in similar preparations  from thymus-bearing 
animals (25). These lower values may not be solely the result of a smaller number of 
TdT producing cells, but may also reflect a  decreased synthesis of this enzyme per 1308  T-CELL LYMPHOMA INDUCTION IN ATHYMIC NUDE MICE 
cell.  This  is  likely  to  be  the  case  in  the  nude  mouse  lymphomas  which,  though 
homogeneous with respect to cell type, showed TdT values only some fivefold higher 
than those found in nude mouse bone marrow cells after fractionation. 
Finally, it is of interest that the same virus (RadLV), inoculated into different hosts 
(C57BL/Ka or nude  mice), is able to replicate in and transform target cells which, 
though  of T-cell  lineage,  are  nonetheless  different  with  respect  to  their  stage  of 
differentiation.  Despite their target cell differences, cell lines derived from these two 
types  of lymphomas  originating  in  different  tissues  continue  to  produce  progeny 
viruses  in  vitro  which  have serological,  biochemical,  and  biological  characteristics 
apparently identical to those of the parental inducing virus. 
Summary 
We report the development of extrathymic lymphoblastic lymphomas in RadLV- 
inoculated congenitally athymic nude mice. Thus, a leukemogenic virus which appears 
to require the presence of a thymus for its replication in normothymic mice can infect 
and transform target cells in the absence of this organ in the athymic host. The cells 
of one of these lymphomas have been established  in  vitro as a  permanent cell line, 
BALB/Nul.  This cell line as well as a  lymphoma induced  in NIH/Swiss nude mice 
exhibit several T-cell markers, including terminal deoxynucleotidyl transferase activ- 
ity, Thy-l.2, and Ly-2.2, but not Ly-l.2 nor TL. Ig determinants were not detected. 
The characteristics of the tumor cells support the view that cells with T-cell markers 
may normally exist in nude mice and undergo neoplastic transformation and clonal 
expansion after infection with a  leukemogenic virus. The alternative possibility that 
virus-induced differentiation of prothymocytes may lead to the expression of Thy-1.2 
and Ly-2.2 antigens is also considered. BALB/Nul cells release large numbers of type 
C  viral paticles.  The virus, designated radiation  leukemia virus  (RadLV)/Nul,  has 
RTase  activity  and  the  protein  profile  characteristic  of  murine  leukemia  virus 
(MuLV). In radioimmunoassays, it cross-reacts completely with RadLV/VLs, a virus 
obtained  from RadLV-induced  C57BL/Ka thymic lymphoma cells in  culture,  and 
slightly with a xenotropic virus (BALB:virus-2) and with AKR MuLV. On inoculation 
into C57BL/Ka mice it has thymotropic and leukemogenic activity. In vitro it is B- 
tropic,  poorly  fibrotropic,  and  has  limited  xenotropic  activity.  Thus,  RadLV/Nul 
appears to be biologically and  serologically similar or identical  to  its  parent  virus, 
RadLV. 
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